This guideline outlines evidence-based recommendations for managing adult lead exposure, emphasizing that adverse health effects can occur at blood lead levels (BLLs) below 40 μg/dL. Key recommendations include: removing individuals from occupational lead exposure if a single BLL exceeds 30 μg/dL or if two consecutive BLLs measured over a 4-week
